ArticleBMC pulmonary medicine2026
Monocyte distribution width as an adjunctive biomarker for differentiating pulmonary tuberculosis from cavitary nontuberculous mycobacterial pulmonary disease.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRapid discrimination between pulmonary tuberculosis (PTB) and nontuberculous mycobacterial pulmonary disease (NTM-PD) remains clinically challenging, particularly in cavitary disease where radiological findings may overlap. Monocyte distribution width (MDW), automatically reported by contemporary hematology analyzers, has emerged as a potential biomarker of systemic immune activation; however, its role in differentiating PTB from cavitary NTM-PD remains unclear.
methodsWe retrospectively reviewed the records of consecutive patients diagnosed with PTB or NTM-PD at our institution between May 2021 and February 2025. All PTB cases were confirmed by culture and/or nucleic acid amplification testing (NAAT) identifying Mycobacterium tuberculosis; no cases were diagnosed solely on smear positivity. Clinical characteristics and laboratory data, including MDW, were compared between groups. Multivariable logistic regression analyses were performed using prespecified parsimonious models to minimize overfitting.
resultsOf the 115 patients, 73 had PTB and 42 had NTM-PD, including 18 with cavitary NTM-PD. Compared with patients with cavitary NTM-PD, patients with PTB had significantly lower lymphocyte counts and hemoglobin and albumin levels, and higher C-reactive protein levels and MDW. In multivariable analysis comparing all PTB cases with cavitary NTM-PD, MDW demonstrated a directional association with PTB after adjustment for radiological extent (adjusted OR 1.37, 95% CI 0.98–1.92, P = 0.066), whereas radiological grade remained independently associated (adjusted OR 0.15, 95% CI 0.04–0.52, P = 0.003). Receiver operating characteristic analysis of MDW yielded an area under the curve of 0.779, which should be interpreted as exploratory given the limited sample size and lack of independent significance.
conclusionIn this single-center retrospective study, MDW demonstrated a directional association with PTB and may provide adjunctive information during early clinical assessment of cavitary mycobacterial disease while awaiting microbiological confirmation. However, MDW was not independently predictive after multivariable adjustment, and its discriminatory performance should be interpreted cautiously. Larger prospective, multicenter studies are required to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.